Levosimendan Administration and Outcome in Cardiac Surgery

• Status: Completed
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the effects on outcome of levosimendan with respect to timing of its administration on the postoperative course of high-risk cardiac surgery patients in a retrospective observational study.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Charite University, Berlin, Germany
• Treatments: Simendan

Criteria

Inclusion Criteria:

• patients undergoing cardiac surgery between 2006 and 2013

• levosimendan administration within 24 hours of postoperative ICU admission

Exclusion Criteria:

• patients younger than 18